Pregnancy in Charcot-Marie-Tooth disease

Objective To collect information on frequency of pregnancy and delivery complications in Charcot-Marie-Tooth (CMT) disease and on CMT course during pregnancy. Methods Through an ad hoc online questionnaire, we investigated pregnancy and neuropathy course in women with CMT adhering to the Italian CMT Registry. Data were compared to those of controls (recruited among friends and unaffected relatives) and the Italian (or other reference) population. Results We collected data on 193 pregnancies from 86 women with CMT (age 20–73 years) with 157 deliveries (81.4%) after a mean of 38.6 gestational weeks. In women with CMT, there were no differences compared to controls (59 pregnancies and 46 deliveries from 24 controls) and the reference population for miscarriages (11.4%) and planned (21.0%) and emergency (14.0%) cesarean sections. We found a significantly higher frequency of placenta previa (1.6% vs 0.4%), abnormal fetal presentations (8.4% vs 4.5%), and preterm deliveries (20.3% vs 6.9%; most in week 34–36 of gestation) compared to reference populations. Excluding twins, newborn weight did not differ from the reference population. Postpartum bleeding rate in patients with CMT (2.1%) was similar to that of the general population (2.4%). CMT status worsened during 18 of 193 pregnancies (9.3%) with no recovery in 16 of them and with similar figures in the CMT1A and non-CMT1A subtypes. Conclusions We observed higher rates of placenta previa, abnormal presentations, and preterm deliveries in CMT, but pregnancy outcome and newborn weight and health were similar to those of the reference populations. Worsening of CMT is not infrequent and occurs not only in CMT1A. Pregnant women with CMT should be monitored with particular care.

[1]  S. Rudnik-Schöneborn,et al.  Pregnancy outcome in Charcot–Marie–Tooth disease: results of the CMT‐NET cohort study in Germany , 2020, European journal of neurology.

[2]  T. Todros,et al.  Risk of adverse pregnancy outcomes by pre-pregnancy Body Mass Index among Italian population: a retrospective population-based cohort study on 27,807 deliveries , 2019, Archives of Gynecology and Obstetrics.

[3]  G. Cavaletti,et al.  The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage , 2018, Orphanet Journal of Rare Diseases.

[4]  F. Parazzini,et al.  Is the Robson’s classification system burdened by obstetric pathologies, maternal characteristics and assistential levels in comparing hospitals cesarean rates? A regional analysis of class 1 and 3 , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[5]  D. Pareyson,et al.  New developments in Charcot–Marie–Tooth neuropathy and related diseases , 2017, Current opinion in neurology.

[6]  F. Parazzini,et al.  Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants? , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[7]  K. Zerres,et al.  Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[8]  S. Rudnik-Schöneborn,et al.  179th ENMC international workshop: Pregnancy in women with neuromuscular disorders 5–7 November 2010, Naarden, The Netherlands , 2012, Neuromuscular Disorders.

[9]  Özge Tunçalp,et al.  National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis , 2011, The Lancet.

[10]  T. Župić,et al.  [Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease]. , 2010, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[11]  C. Berg,et al.  Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group , 2009, BMC pregnancy and childbirth.

[12]  Davide Pareyson,et al.  Diagnosis, natural history, and management of Charcot–Marie–Tooth disease , 2009, The Lancet Neurology.

[13]  M. Shy,et al.  Women and men are equally disabled by Charcot–Marie–Tooth disease type 1A , 2007, Neurology.

[14]  N. Gilhus,et al.  Pregnancies and deliveries in patients with Charcot–Marie–Tooth disease , 2005, Neurology.

[15]  Ambarina S. Faiz,et al.  Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[16]  D. D'urso,et al.  Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: Possible mechanisms of action , 1999, Journal of neuroscience research.

[17]  J. Huisman The Netherlands , 1996, The Lancet.

[18]  L. Fedele,et al.  Weight at birth by gestational age in Italy. , 1995, Human reproduction.

[19]  K. Zerres,et al.  Pregnancy and delivery in Charcot‐Marie‐Tooth disease type 1 , 1993, Neurology.

[20]  L. Fedele,et al.  Determinants of caesarean section rates in Italy , 1992, British journal of obstetrics and gynaecology.

[21]  M. Kritchevsky,et al.  Exacerbation of Charcot‐Marie‐Tooth disease in pregnancy , 1982, Neurology.